drugset
drugset / Trial / NCT03560934

Tetrahydrocannabinol (THC) and Sleep

NCT03560934 ↗

Phase 0 Completed 18 enrolled Oregon Health and Science University
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The investigators will test the effects of 10-60mg dronabinol (oral THC) on sleep in non-frequent and frequent cannabis users.

Timeline

Start
2018-09-01
Primary completion
2021-09-19
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 10 mg Oral
Subject Dronabinol Other / unclassified 60 mg Oral

Indications

No indication recorded.